Common | Jotup

Aluminum Association Requests Ruling that Certain Imports from Korea are Circumventing Unfair Trade Orders on Common Alloy Aluminum Sheet from China

Retrieved on:

Thursday, March 16, 2023

CAAS, The Aluminum Association, Office of Inspector General, U.S. Department of Health and Human Services, Working Group, Commerce Department trade mission controversy, Aluminium, Common, Active Measures Working Group, CVD, Kelley Drye & Warren, AD, U.S. Department of Commerce Office of Security, United States Department of Commerce, Commerce, Cryptocurrency, Recycling

“We urge the Commerce Department to take action promptly to enforce our trade laws against efforts by a Chinese producer and its Korean affiliate to evade the unfair trade orders on common alloy aluminum sheet from China,” said Charles Johnson, president and CEO of the Aluminum Association.

Key Points:

“We urge the Commerce Department to take action promptly to enforce our trade laws against efforts by a Chinese producer and its Korean affiliate to evade the unfair trade orders on common alloy aluminum sheet from China,” said Charles Johnson, president and CEO of the Aluminum Association.
The aluminum sheet at issue includes both unclad aluminum sheet, as well as multi-alloy, clad aluminum sheet.
In February 2019, the Commerce Department published antidumping and countervailing (AD/CVD) orders on imports of CAAS from China following an action by the Aluminum Association’s Common Alloy Aluminum Sheet Trade Enforcement Working Group.
Since those orders were published, U.S. imports of aluminum sheet from China have declined substantially.

OBSI 2022 Annual Report released: Complaint inquiries and opened cases reach new record highs in 2022, fraud complaints dramatically rise

Retrieved on:

Thursday, March 16, 2023

Crypto, St. Louis Fed Financial Stress Index, Common, Fraud, Complaint, Knowledge, Ombudsman, Bank, Retail, Cryptocurrency, Investment

In 2022, OBSI responded to over 10,000 public inquiries - a 40% year-over-year increase from the record levels reached in 2021.

Key Points:

In 2022, OBSI responded to over 10,000 public inquiries - a 40% year-over-year increase from the record levels reached in 2021.
In total, OBSI opened 1,151 cases in 2022, establishing a new record with a year-over-year increase of 6% from the previous record set in 2021.
Banking cases increased 33% year over year to 686 in 2022, up from 514 cases in 2021.
Investment cases decreased overall by 18% in 2022 to 465, down from 568 cases in 2021 and on par with the number of cases opened in 2020.

Stellantis Announces Launch of the First Tranche

Retrieved on:

Thursday, March 16, 2023

Share repurchase, Acquisition, Market abuse, Common, Euronext Paris, JV, NYSE, Security (finance), EU, Stellantis

This agreement relates to the first tranche of the Program.

Key Points:

This agreement relates to the first tranche of the Program.
This tranche will cover a maximum amount of up to €500 million.
The first tranche of the Program shall start on March 17, 2023 and end no later than June 19, 2023.
Common shares purchased under the Program will be cancelled in due course.

WM Technology, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on:

Thursday, March 16, 2023

WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS), a leading technology and technology solutions provider to the cannabis industry, today announced its financial results for the fourth quarter ending December 31, 2022.

Key Points:

WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS), a leading technology and technology solutions provider to the cannabis industry, today announced its financial results for the fourth quarter ending December 31, 2022.
“Our fourth quarter results, consistent with our prior guidance, reflect both the continued importance of WM Technology to our clients and users as well as the challenging operating environment that exists today in cannabis,” said Doug Francis, Executive Chair of WM Technology.
Total shares outstanding across Class A and Class V Common Stock were 147.5 million as of December 31, 2022.
Revenue was $215.5 million for the year ended December 31, 2022, as compared to $193.1 million in the prior year.

OffSec Releases 2023 Edition of its Industry-Leading Penetration Testing Course for Rising Cybersecurity Professionals

Retrieved on:

Thursday, March 16, 2023

Test management, Module, Learning object, Penetration, Market, Organization, Certification, SQL injection, Common, Lateral movement, Environment, Penetration test, OSCP, Report, Introduction, Tutoring, Nursing, Enumeration

NEW YORK, March 16, 2023 /PRNewswire/ -- OffSec, the leading provider of hands-on cybersecurity education for individuals and organizations of all sizes, today released the newest edition of Penetration Testing with Kali Linux (PEN-200), the premier pentesting course on the market. Its associated certification, the Offensive Security Certified Professional, or OSCP, is widely considered the global gold standard in pentesting certifications.

Key Points:

Its associated certification, the Offensive Security Certified Professional, or OSCP, is widely considered the global gold standard in pentesting certifications.
As a component of fulfilling the most recent PWK learning objectives, learners will acquire foundational comprehension of the penetration testing methodology, discern and classify risks, and carry out a guided penetration test.
"OffSec's Penetration Testing with Kali Linux course has been thoroughly updated to address modern threats and methods, allowing organizations to feel confident that their team members have received the best preparation possible."
The OSCP certification is considered to be more technical than other ethical hacking certifications and is one of the few that requires evidence of practical penetration testing skills.

EQS-News: Marinomed Biotech AG reports positive clinical data for the Carragelose decongestant nasal spray

Retrieved on:

Thursday, March 16, 2023

Rhinitis, Risk, VSE, Trial of the century, CSO, Allergy, Nose, Patient, Common, Nasal congestion, Viral, Clinical trial, MDR, Vienna, Medical device regulation, Wiener Börse, Pharmaceutical industry, Sorbitol

Korneuburg, Austria, 14 March 2023 – Marinomed Biotech AG, listed on the Vienna Stock Exchange (VSE:MARI), today announced positive results from its clinical study on the decongestant effect of the Sorbitol-containing Carragelose nasal spray.

Key Points:

Korneuburg, Austria, 14 March 2023 – Marinomed Biotech AG, listed on the Vienna Stock Exchange (VSE:MARI), today announced positive results from its clinical study on the decongestant effect of the Sorbitol-containing Carragelose nasal spray.
While Carragelose was shown to be an effective treatment of viral infections of the respiratory tract, Sorbitol exerts a decongestant effect.
The Carragelose and Sorbitol nasal spray was launched in 2018 and is currently marketed in 11 countries as a common cold product.
Based on the current clinical results, Marinomed plans to expand both the applications and target markets for the decongestant nasal spray.

MedAvail Announces Closing of $16 Million Private Placement

Retrieved on:

Tuesday, March 14, 2023

Sale, Offering, Warrant, Exercise, Exchange, Common, Prospectus, Security (finance)

PHOENIX, March 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that on March 13, 2023, it closed a private placement (the “Offering”) of securities with certain institutional investors pursuant to the terms of a definitive securities purchase agreement dated March 9, 2023.

Key Points:

PHOENIX, March 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that on March 13, 2023, it closed a private placement (the “Offering”) of securities with certain institutional investors pursuant to the terms of a definitive securities purchase agreement dated March 9, 2023.
MedAvail received gross proceeds from the Offering of approximately $16 million, before deducting offering expenses.
Any offering of the securities under the resale registration statements will only be made by means of a prospectus.
H.C. Wainwright & Co. acted as financial advisor for the private placement.

Dermavant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old

Retrieved on:

Wednesday, March 15, 2023

“Atopic dermatitis, the most common type of eczema, affects more than 9.6 million children and 16.5 million adults in the United States.

Key Points:

“Atopic dermatitis, the most common type of eczema, affects more than 9.6 million children and 16.5 million adults in the United States.
In the U.S., VTAMA cream is already approved for the topical treatment of plaque psoriasis in adults.
Importantly, VTAMA cream data indicated no safety or tolerability signals in this population including children as young as 2 years old.
“Atopic dermatitis can have a negative impact on the quality of life of diagnosed children as well as their families.

AMC Entertainment Holdings, Inc. Announces Results of Special Meeting of Stockholders

Retrieved on:

Tuesday, March 14, 2023

Entertainment, Theatre, Film & Motion Pictures, Stock split, Delaware Court, Special, Proxy, Delaware Court of Chancery, Ape, NYSE, Judgement, Common, Computershare, AMC Theatres, APE, Shareholder, AMC, Holding company, Security (finance)

AMC Entertainment Holdings, Inc. (NYSE: AMC and APE) (“AMC” or “the Company”), the largest theatrical exhibition company in the world, announced today that its shareholders approved both the Share Increase Proposal and the Reverse Split Proposal at its Special Meeting of Stockholders held today, March 14, 2023.

Key Points:

AMC Entertainment Holdings, Inc. (NYSE: AMC and APE) (“AMC” or “the Company”), the largest theatrical exhibition company in the world, announced today that its shareholders approved both the Share Increase Proposal and the Reverse Split Proposal at its Special Meeting of Stockholders held today, March 14, 2023.
Commenting on the results, Adam Aron, AMC Entertainment Chairman and CEO said, “AMC’s shareholders exercised their rights today to have their voices be heard.
If implemented, AMC should have an ability to raise a significant amount of equity capital in the months and years ahead.
Stockholders voted in favor of each proposal, as follows:
The Share Increase Proposal was approved.

The Relay Global Market to Reach $14.7 Billion by 2030: Increasing Power Demand and Investments in Smart Grid Infrastructure Presents Opportunities

Retrieved on:

Wednesday, March 15, 2023

Based on the type of relay, the Electromechanical Relay is estimated to be the largest-growing market from 2022 to 2030.

Key Points:

Based on the type of relay, the Electromechanical Relay is estimated to be the largest-growing market from 2022 to 2030.
Rising energy prices are driving the demand for advanced electromechanical relays to reduce power consumption.
The rising number of renewable energy projects is also fueling the demand for high-capacity electromechanical relays, thus positively impacting the growth of the global relay market.
Increasing demand for electromechanical relays due to their low cost, long operation life, less power consumption, and easy maintenance is augmenting the market growth.